Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Original Research
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
3,322 | Dovepress* | 3,058+ | 87 | 3,145 | |
PubMed Central* | 264 | 127 | 391 | ||
Totals | 3,322 | 214 | 3,536 | ||
*Since 27 February 2023 |
View citations on PubMed and Google Scholar